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Abstract  24 
Objective Increasing numbers of children with HIV are surviving to adolescence and 25 
encountering multiple clinical and social consequences of longstanding HIV infection. We 26 
aimed to investigate the association between HIV and disability, social functioning and school 27 
inclusion among 6 to 16-year olds in Zimbabwe. 28 
Methods HIV-infected children receiving antiretroviral therapy from a public-sector HIV 29 
clinic, and HIV-uninfected children attending primary care clinics in the same catchment area 30 
were recruited. Standardised questionnaires were used to collect sociodemographic, social 31 
functioning and disability data. Multivariable logistic regression was used to assess the 32 
relationship between HIV status and disability and social functioning.  33 
Results We recruited 202 HIV-infected and 285 HIV-uninfected children. There was no 34 
difference in age and gender between the two groups, but a higher proportion of HIV-infected 35 
children were orphaned. The prevalence of any disability was higher in HIV-infected than 36 
uninfected children (37.6% vs. 18.5%, p<0.001). HIV-infected children were more likely to 37 
report anxiety (adjusted odds ratio (aOR) 4.4; 95% CI 2.4, 8.1), low mood (aOR 4.2; 2.1, 8.4) 38 
and difficulty forming friendships (aOR 14.8; 1.9, 116.6) than uninfected children. Children 39 
with HIV also reported more missed school days, repeating a school year and social exclusion 40 
in class. These associations remained apparent when comparing children with HIV and 41 
disability to those with HIV but no disabilities.  42 
Conclusions Children with HIV commonly experience disabilities, and these are associated 43 
with social and educational exclusion.  Rehabilitation and support services are needed to 44 
facilitate educational attainment and social participation in this population.  45 
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Introduction  46 
In 2016, worldwide approximately 160,000 children were newly infected with HIV (1). Of the 47 
estimated 2.1 million children aged under 15 years living with HIV, nearly 90% live in Sub-48 
Saharan Africa (SSA) (1).  The global scale-up of antiretroviral therapy (ART) programmes 49 
has meant that increasing numbers of children with HIV who would previously have died in 50 
infancy without treatment are now surviving to older childhood and adolescence. However, 51 
there is increasing evidence that childhood HIV infection is associated with chronic multi-52 
system complications, resulting in hearing, cognitive, mobility and visual impairments (2, 3).  53 
HIV may lead to impairments through a variety of mechanisms.  For example, HIV-mediated 54 
immunosuppression may lead to opportunistic infections such as CMV that can cause visual 55 
impairment (4). The risk of impairments is increased if initiation of ART is delayed, as is 56 
common in many resource-limited settings (5).  ART itself may also contribute to impairment; 57 
for instance, nucleoside analogue reverse-transcriptase inhibitors (NRTI) commonly used at 58 
the time of ART roll out for children in SSA (e.g. stavudine and lamuvidine) is linked to hearing 59 
loss (6, 7). Zidovudine has been independently linked to myopathy (8), which may lead to 60 
physical impairments. Once established, impairments may not be completely reversed by ART 61 
(9) and negatively impact on social functioning and schooling (3, 10). In other words, HIV or 62 
its treatment may lead to disability, which is defined as the restriction of participation in society 63 
of an individual due to an underlying impairment in combination with attitudinal and 64 
environmental and other barriers (11). Socio-economic deprivation, often associated with HIV 65 
infection (12), potentially exacerbates disability by further restricting participation in society. 66 
To optimise the quality of life and long-term care amongst those living with HIV and their 67 
families, HIV programmes need to broaden their focus and address longer-term consequences 68 
of HIV infection, including the impact on schooling and social inclusion. Even in the absence 69 
of HIV, education and schooling are a major global concern for children and adolescents with 70 
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disabilities, who are substantially less likely to be enrolled in school and, even when enrolled, 71 
lag behind their peers in educational attainment (13). HIV is likely to magnify these issues 72 
among children due to poverty resulting from parental ill health, food insecurity and 73 
unemployment (14).  74 
We therefore conducted a cross-sectional study to investigate the association between HIV and 75 
disability, social functioning and school inclusion among HIV-infected children compared to 76 
uninfected peers in Zimbabwe. 77 
Methods 78 
Study setting and participants  79 
HIV-infected children aged 6 to 16 years and receiving either first or second line ART for at 80 
least six months were consecutively recruited from Harare Central Hospital (HCH); this is the 81 
largest public-sector hospital in Harare, providing HIV care for more than 3,000 children. This 82 
age range was selected because it represents children of school going age. Recruitment was 83 
restricted to the first five eligible participants a day for logistical ease.  Exclusion criteria were 84 
being acutely ill i.e. having a respiratory tract or other acute infection or tuberculosis, not 85 
residing in Harare and no guardian consent and/or participant assent.  86 
 87 
A comparison group of HIV-uninfected children aged 6-16 years was recruited from primary 88 
health care clinics (PHC) in seven high-density communities from the same catchment area 89 
served by the clinic from which the HIV-infected participants were enrolled. Provider initiated 90 
HIV testing and counselling was offered by the PHCs to all children attending for acute care 91 
regardless of the reason for presentation, and those who tested HIV-negative were invited to 92 
participate and attend pre-booked appointments for assessments. The same exclusion criteria 93 
were applied to HIV-uninfected children.  94 
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Data collection  95 
Socio-demographic data including age, sex and orphan status were recorded. Trained research 96 
nurses administered standardised questionnaires to collect data on disability, education and 97 
social functioning.  The Washington Group/UNICEF Child Functioning and Disability 21 98 
Question Set was administered jointly to all children and caregivers by a research nurse to 99 
assess disability (15). This question set is validated for children aged 2-17 years. Self-reported 100 
functional difficulties were defined as binary variables in the following domains: vision, 101 
hearing, walking, speech, learning, memory, self-care, anxiety, low mood, difficulty 102 
controlling behaviour, dealing with change, forming friendships and concentration. Disability 103 
was defined as reported difficulties in any of the functional domains. Additional information 104 
on school and social functioning was collected, including the following: school enrolment, 105 
school attendance, repeated school year, problems getting help from teachers and friends, 106 
interaction with other children (leadership, play, bullying) and inclusion in lessons and school 107 
activities. Caregivers of HIV-infected children were asked additional questions relating to HIV 108 
diagnosis, testing, ART history, and children’s awareness of diagnosis. At the time of 109 
enrolment, CD4 count was determined using an Alere PIMA CD4+ (Waltham, Massachusetts, 110 
USA) and HIV viral load was measured using COBAS Ampliprep/Taqman 48 Version 2.0 111 
(Roche, Rotkreuz, Switzerland). 112 
Ethics 113 
Ethical approval was obtained from the Medical Research Council of Zimbabwe 114 
(MRCZ/A/1856), the Biomedical Research and Training Institute (AP125) Institutional 115 
Review Board, Harare Hospital Ethics Committee and the London School of Hygiene and 116 
Tropical Medicine (LSHTM) Ethics Committee (8263). All guardians gave written consent, 117 
and participants gave assent to participate in the study. 118 
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Data management and analysis 119 
Data were collected using paper forms and entered into a Microsoft Access database using 120 
optical mark recognition software (Cardiff TELEFORM Intelligent Character, Version 10.7), 121 
which has inbuilt quality control checks. Paper forms were manually checked for missing data 122 
and inconsistencies before being captured. Further internal and external consistency checks 123 
were carried out using database queries. 124 
Data completeness was assessed by summary and descriptive statistics. There was a low 125 
proportion of missing data (<6%) in HIV-infected and uninfected children for demographic, 126 
clinical, disability and school functioning and social inclusion data. The prevalence of 127 
functional difficulties and disability was summarised as frequencies and percentages for each 128 
variable by HIV status. Continuous variables were summarised as mean and standard deviation 129 
(SD) when normally distributed and median and interquartile range (IQR) when not. 130 
Univariable logistic regression analysis was used to compare functional, school and social 131 
outcomes between HIV-infected and uninfected children. Multivariable logistic regression was 132 
used to adjust each functional outcome of interest for a priori defined variables of age and sex. 133 
Orphan status and previous infection/co-morbidity did not significantly affect the fit of the 134 
model (p<0.05) on likelihood ratio testing and therefore were excluded. Hence, the final model 135 
was adjusted for age and sex alone. All statistical analyses were carried out using Stata v13.0 136 
(College Station, Texas: StataCorp LP). 137 
 138 
Results  139 
Baseline characteristics of participants 140 
We recruited 202 HIV-infected children (median age 11 years [IQR 8-13]; 48.0% female) and 141 
285 uninfected children (median age 10 years [IQR 8-13]; 48.8% female). There were no 142 
significant differences in age or sex between the two groups, but HIV-infected children were 143 
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more likely to be orphaned (p<0.001) (Table 1). Among HIV-infected children, the median age 144 
at HIV diagnosis was 5 years [IQR 3-7] and the median CD4 count was 726 cells/ μl [IQR 476-145 
941]. The median duration of ART was 2 years [IQR 1-5] and the median age of ART initiation 146 
was 8 years [IQR 5-10].  147 
 148 
Functioning and disability 149 
The prevalence of any self-reported difficulties in functioning (i.e. disability) was higher in 150 
HIV-infected children compared to uninfected children (37.6% compared to 18.8% p<0.001) 151 
(Table 2). Amongst those with HIV, the most common types of disability were learning 152 
(reported by 23.2%) and memory difficulties (reported by 17.8%). Difficulties with seeing 153 
(7.7%), hearing (4.8%) and walking (2.5%) were also reported more commonly amongst HIV 154 
infected children. 155 
After adjustment for age and sex, the odds of any disability were 2.8 times higher in HIV-156 
infected than HIV-uninfected children (95% CI 1.8, 4.2 p<0.001). HIV-infected children were 157 
significantly more likely to report visual (aOR 3.0; 1.3, 6.9), hearing (aOR 3.4; 1.0, 10.5), 158 
speech (aOR 3.8; 1.1, 13.9), learning (aOR 3.9; 1.4, 3.4) and memory problems (aOR 3.5; 2.0, 159 
6.6) (Table 2). In addition, HIV-infected children were more likely to report anxiety (aOR 4.4; 160 
2.4, 8.1), low mood (aOR 4.2; 2.1, 8.4) and difficulty forming friendships (aOR 14.8; 1.9, 161 
116.6) compared to their uninfected peers. There was no significant association between age 162 
at HIV diagnosis, age of ART initiation, CD4 count, viral load, ART duration or previous 163 
comorbidity and disability among HIV-infected children (Table 3).  164 
  165 
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Schooling and social inclusion 166 
School enrolment rates were high among all children (96.0% in both HIV-infected and 167 
uninfected groups). However, children living with HIV were more likely to have repeated a 168 
school year (aOR 3.2; 1.6, 3.8) and on average, missed more days of school in the preceding 169 
month (mean 0.9 days (range 0-15 days) vs. 0.3 days (range 0-7 days). HIV-infected children 170 
more frequently reported not receiving help from teachers (aOR 2.1; 1.2, 3.8) or friends (aOR 171 
3.0; 2.0, 4.5) at school. They were more likely to feel excluded in lessons and activities (aOR 172 
4.7; 2.7, 8.3) and more likely to be physically and verbally bullied by other children (aOR 3.7; 173 
2.2, 6.0). Among children with HIV, those with disabilities were less likely to be enrolled in 174 
the same school grade as their age peers (aOR 3.3; 1.7, 6.1) and more likely to repeat a school 175 
year (aOR 1.9; 1.0, 3.6) compared to HIV-infected peers without disability.  They were also 176 
more likely to report that their peers did not look up to them as leaders (aOR 2.1; 1.4, 3.4) and 177 
that they experienced violence from their peers (aOR 2.5; 1.3, 4.8) (Table 4). Amongst children 178 
with disability, those with HIV were less likely to be enrolled in school, more likely to have 179 
needed to repeat a school year and much more likely to have been physically or verbally bullied 180 
than disabled children without HIV (Supplementary Table 5). 181 
Discussion  182 
This study demonstrates a high prevalence of physical and cognitive functional difficulties 183 
among HIV-infected children compared to their uninfected peers. Children with HIV were 184 
more likely to report low mood, anxiety, difficulty forming friendships, repeating a school year 185 
and to experience poor social support at school, particularly when HIV and disability co-186 
existed. 187 
Other studies have reported increased physical, sensory and cognitive difficulties in HIV-188 
infected children compared to those uninfected (3,16-22). Developmental delay is strongly 189 
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associated with HIV in SSA (2), affecting up to 78% of children (22). Fortunately, in the post-190 
ART era, severe forms of cognitive impairment in children appear to be decreasing; however, 191 
the prevalence of mild impairment remains largely unchanged and may even be increasing 192 
(23). A number of studies have assessed the prevalence of cognitive (18, 22, 24, 26-29) and 193 
motor (18, 19, 21, 23-29) impairments among HIV-infected and uninfected children; however, 194 
to date these have largely focused on infants and younger children before school age. Our study 195 
highlights both the increased prevalence of learning difficulties among HIV-infected school-196 
age children, but also shows that learning difficulties are common in uninfected children in 197 
Zimbabwe. 198 
This study further demonstrates the additional burden of low mood and anxiety amongst HIV-199 
infected children. There is evidence of a strong bidirectional association between mental health 200 
and educational attainment with mood and anxiety disorders having a direct effect on early 201 
school leaving, substance misuse and disruptive behavioural disorders (30). Mental health 202 
issues impact negatively on treatment compliance and retention in social care and school 203 
through the fear of disclosing HIV status and social ostracism (31). Socialising and making 204 
friends at school are key protective factors for psychosocial wellbeing in children with HIV, 205 
whereas negative peer interactions such as lack of friends, bullying and being beaten by friends 206 
have been identified as risks (32). Therefore, school peer support interventions should be 207 
adopted as they have been shown to reduce psychological distress, depression, anxiety and 208 
anger in children with HIV (33, 34). 209 
Similar to our findings, a recent Malawian cross-sectional study found that a high proportion 210 
of HIV-infected school children had hearing impairment identified by extensive audiological 211 
testing (10). These children were less likely to attend school and had poorer emotional and 212 
school functioning than HIV-infected children without hearing loss. Furthermore, only 40% of 213 
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caregivers accurately perceived their child’s hearing loss, and few had sought treatment, 214 
implying that routine screening may be necessary as disability may be underreported (10).  215 
Our study found no significant association between HIV disease severity or treatment factors 216 
and disability. However, previous studies have shown a relationship between CD4 count, viral 217 
load at enrolment, ART duration and disability (2,10). The Malawian study mentioned above 218 
(10) found hearing loss to be significantly associated with HIV WHO Stage 3 or 4 disease, but 219 
not duration of ART or CD4 count. A recent systematic review of disability and HIV in SSA 220 
found a significant dose-response relationship between indicators of disease progression (CD4 221 
or WHO stage) and disability in 48% of studies (2). The evidence suggests that earlier ART 222 
initiation in children may reduce the risk of impairments and consequent disability, but once 223 
established, ART alone may not be sufficient to enable children with HIV to lead healthy lives 224 
(2). 225 
Given the high prevalence of physical and sensory impairments amongst children living with 226 
HIV, our study underlines the need for increased availability of rehabilitation services to 227 
support school age children and adolescents with HIV. Currently, the few existing services are 228 
mainly located in urban areas or private health facilities which limits access for many (35). 229 
Greater support for children with learning difficulties is required in schools to facilitate social 230 
inclusion and educational attainment (36) as learning, remembering, and concentration appear 231 
to be common in HIV-infected and uninfected children. 232 
Although incorporating disability inclusive approaches into HIV treatment and care is likely to 233 
increase the social participation and school functioning of children with HIV (37), so far only 234 
5 of 18 countries (27%) in Eastern and Southern Africa have recognised the need for specific 235 
support services and interventions for people with disabilities in their national strategic 236 
responses to HIV and AIDS (38). Although Zimbabwe is one of these countries, the findings 237 
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of this study suggest that further work is required to extend services to support school age 238 
children with HIV.  239 
To our knowledge, this is the first study to estimate the prevalence of disability and its 240 
association with school and social functioning in HIV-infected and uninfected older children 241 
in a Sub-Saharan African population.  Study limitations include the potential selection bias 242 
from non-probability based sampling: selecting the first five children attending the HIV clinic 243 
may have led to under-reported disability if children with physical or behavioral disabilities 244 
were more likely to attend at clinic later. Alternatively, children with disabilities may have 245 
been less likely to go to school and thus be the first to attend.  Furthermore, misclassification 246 
and/or recall bias from the use of self-reported functional difficulties and disability without 247 
contemporaneous clinical measures of the impairments or their cause, coupled with the fact 248 
that carers may not accurately perceive their children’s functional difficulties, may have also 249 
led to under-reported disability.  250 
Unfortunately, socioeconomic data such as household income and size, asset ownership, 251 
caregiver education and food security were not available which meant that analyses could not 252 
be adjusted for socio-economic status. This is important as poverty and disability are likely to 253 
reinforce each other, leading to vulnerability and exclusion. Children who are poor are more 254 
likely to become disabled through poor healthcare, malnutrition, or dangerous living 255 
conditions. Once disabled, they are more likely to be denied basic resources that would mitigate 256 
deepening poverty (39). There is evidence that poverty is a major contributor to poor treatment 257 
adherence among in HIV-infected children. (40). Furthermore, evidence from a large cross-258 
sectional study of South African adolescents from deprived urban areas showed that 259 
orphanhood by AIDS was significantly related to childhood depression, peer problems, post-260 
traumatic stress and behavioural problems; however, adjusting for poverty indictors in this 261 
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study attenuated the association between AIDS-orphanhood and these psychological problems 262 
(41). 263 
Although it is evident that disability is common in HIV-infected children and has a major 264 
impact on their lives, further research to understand the aetiology of different impairments is 265 
needed to inform the design of effective interventions and appropriate rehabilitation services. 266 
Examples of the type of interventions for HIV-infected children that could be introduced 267 
include: 1) routine screening for impairments 2) linking HIV care to rehabilitation and 268 
additional clinical services (e.g. ENT in the case of hearing impairment) 3) interventions to 269 
promote school inclusion and social acceptance among children with HIV (e.g. through training 270 
of parents, teachers and peers).  271 
In conclusion, this study suggests physical and cognitive functional difficulties are common 272 
among children with HIV. These difficulties are associated with school exclusion, including 273 
impaired educational progress, difficulty forming friendships and reduced ability to participate 274 
in lessons and activities. Further work is required to develop tools to better detect and 275 
understand the need for rehabilitation and support services within paediatric HIV programmes.  276 
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Tables and Figures 428 
 429 
Table 1. Baseline Characteristics of HIV-infected and HIV-uninfected Children in Zimbabwe 430 
Characteristic 
 
HIV+ 
n=202 
n (%)a 
HIV- 
n=285 
n (%) 
p value 
 
Age    
6 -11 years 132 (65.4) 165 (57.9) 0.06b 
12 -16 years 70 (34.6) 32 (42.1)  
Median (IQR) years 11 (8, 13) 10 (8, 13) 0.61c 
Sex    
Female  97 (48.0) 139 (48.8) 0.11b 
Orphan status     
Single orphan 69 (34.2) 25 (8.8) <0.001b 
Double orphan  28 (13.9) 7 (2.5)  
Not orphaned  98 (48.5) 245 (85.9)  
Age at HIV diagnosis    
Median (IQR) years 5 (3, 7)   
Age at ART initiation    
Median (IQR) years 8 (5, 10)   
ART duration    
<1 years 75 (37.1)   
1-5 years 97 (48.0)   
>5 years 30 (14.9)   
CD4     
<200 cells/μl  9 (4.5)   
200-500 cells/μl  47 (23.2)   
>500 cells/μl  144 (71.3)   
Median (IQR) cells/μl 726 (476, 941)   
Viral load     
<400 copies/ml 152 (75.2)   
400-5000 copies/ml 14 (7.0)   
>5000 copies/ml 32 (15.8)   
Median (IQR) copies/ml 19 (19, 250)   
Abbreviations:  HIV+ HIV-infected, HIV- HIV-uninfected, SD standard deviation, IQR inter 
quartile range 
a) n (%) shown, except for median and IQR shown in italics 
b) p value from χ2 test   
c) p value from Mann-Whitney U test 
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Table 2. Domains of Disability and Functioning in HIV-infected and HIV-uninfected Children 431 
in Zimbabwe 432 
 433 
Outcome 
 
HIV+ 
n=202 
n (%) 
HIV- 
n=285 
n (%) 
Crude OR 
(95% CI) 
p valuea aOR (95% CI) p valuea 
Any disability 76 (37.6) 53 (18.8) 2.3 (1.6, 5.3) <0.001 2.8 (1.8, 4.2) <0.001 
Seeing                                    16 (7.7) 9 (3.1) 2.7 (1.2, 6.0) 0.009 3.0 (1.3, 6.9) 0.009 
Hearing                                 10 (4.8) 4 (1.4) 3.4 (1.1, 10.6) 0.031 3.4 (1.0, 10.5) 0.036 
Walking                                5 (2.5) 1 (0.4) 7.4 (0.9, 63.5) 0.065 7.4 (0.9, 63.5) 0.055 
Speaking                           9 (4.3) 3 (1.1) 4.0 (1.1, 14.5) 0.042 3.8 (1.1, 13.9) 0.042 
Learning                               48 (23.2) 33 (11.6) 2.1 (1.3, 3.2) 0.002 3.9 (1.4, 3.4) 0.001 
Memory                               37 (17.8) 16 (5.6) 3.6 (2.0, 6.6) <0.001 3.5 (2.0, 6.6) <0.001 
Self-caring                       3 (1.5) 1 (0.4) 1.7 (0.4, 8.0) 0.072 1.6 (0.4, 7.8) 0.524 
Anxiety                                 42 (20.3)  14 (5.6) 4.6 (2.4, 8.2) 0.000 4.4 (2.4, 8.1) <0.001 
Depression                            32 (15.5) 12 (4.2) 4.2 (2.1, 8.5) 0.010 4.2 (2.1, 8.4) 0.010 
Controlling behaviour  3 (1.5) 1 (0.4) 4.0 (0.4, 39.4) <0.001 4.0 (0.4, 39.3) 0.003 
Concentration                      2 (1.0) 6 (2.1) 0.4 (0.1, 2.2) 0.478 0.4 (0.1, 2.2) 0.311 
Accepting change  39 (10.9) 36 (12.6) 1.6 (0.9, 2.6) 0.085 1.5 (1.0, 2.5) 0.075 
Making friends  10 (4.8) 1 (0.4) 14.6 (1.9, 115.2) 0.001 14.8 (1.9, 116.6) 0.011 
Abbreviations: HIV+ HIV-infected, HIV- HIV-uninfected, OR odds ratio, aOR age, sex adjusted odds ratio. 
a) p value from χ2 test 
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Table 3. Difference in HIV Characteristics Amongst HIV-infected Children With and Without 435 
Disability in Zimbabwe 436 
 437 
Characteristic 
 
HIV+  
with disability: 
na=76  
HIV+ 
without disability: 
n=126  
p value  
Age   Median (IQR) years 10.9 (2.6) 10.3 (2.6)   
6-9 years 24 (31.6) 48 (38.1) 0.77 - 
10-12 years 31 (40.8) 50 (39.7)   
13-14 years 15 (19.7) 20 (15.9)   
15-16 years 6 (7.9) 8 (6.4)   
Age at diagnosis     
Median (IQR) years  5.0 (3.0) 5.1 (2.9)  - 
Age of ART initiation     
          Median (IQR) years 8 (6, 11) 7 (5, 10) 0.78  
Sex     
Female 35 (46.0) 62 (49.2) 0.66  
 
 
  aOR (95% CI) 
CD4 count      
Median (IQR ) cells/uL 736 (513, 914) 720 (459, 910)   
<200 cells/uL 3 (4.0) 6 (4.7) 0.78 1.0 
200-500 cells/uL 15 (19.7) 32 (25.4)  1.4 (0.8, 2.5) 
>500 cells/uL 57 (75.0) 87 (69.1)   
Viral load      
Median (IQR) copies/ml 19 (19, 190) 19 (19, 343)   
<400 copies/ml 57 (75.0) 95 (75.4) 0.16 1.0 
400-5000 copies/ml 2 (2.6) 12 (9.5)  1.1 (0.7, 1.6) 
>5000 copies/ml 14 (18.4) 18 (14.3)   
ART duration      
Median (IQR) years 2 (1,5) 1 (0, 4)   
<1 years 24 (31.6) 51 (40.5) 0.21 1.0 
1-5 years 39 (51.3) 58 (46.0)  1.2 (0.8, 1.9) 
>5 years 13 (17.1) 17 (13.5)   
No of hospital admissions in 12 months     
>1 5 (6.6) 5 (4.0)  1.9 (0.6, 6.1) 
Past history of TB  29 (38.2) 50 (39.7) 0.94 0.9 (0.5, 1.6) 
Abbreviations HIV+ HIV-infected, HIV- HIV Uninfected, aOR odds ratio adjusted for age and sex, ART antiretroviral 
therapy, TB tuberculosis, IQR inter quartile range. 
a) n shown, except for median and IQR shown in italics 
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Table 4. School and Social Inclusion at School in HIV-infected and HIV-uninfected Children and in HIV-infected Children with and Without Disability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic 
 
HIV+ 
n=202 
n (%) 
HIV- 
n=285 
n (%) 
aOR 
(95% CI) 
HIV+ 
with 
disability 
n=76 
n (%) 
 
HIV+ 
without 
disability 
n=126 
n (%) 
 
aOR 
(95% CI) 
School inclusion as reported by children and their carers 
Currently enrolled in school 194 (96.0) 273 (96.0) 0.98 (0.4, 2.5) 71 (93.4) 123 (97.6) 0.3 (0.1, 1.5) 
Enrolled in the same grade as peers 102 (50.5) 197 (69.1) 2.4 (1.6, 3.6) 24 (31.6) 78 (61.9) 3.3 (1.7, 6.1) 
Ever repeated a year at school 68 (33.7) 53 (18.6) 2.5 (1.6, 3.8) 32 (42.1) 36 (28.6) 1.9 (1.0, 3.6) 
Social inclusion at school as reported by children and their carers 
No help from teachers, if problem at school  4 (2.0) 2 (0.7) 2.1 (1.2, 3.8) 2 (2.6) 2 (1.6) 1.7 (0.9, 3.2) 
No help from friends, if problem at school 15 (7.4) 3 (1.1) 3.0 (2.0, 4.5) 11(14.5) 4 (3.2) 1.5 (0.9, 2.4) 
Child has no friends to play with 2 (1.0) 1 (0.4) 1.8 (0.7, 5.0) 2 (2.6) 1 (0.8) 1.7 (0.8, 5.7) 
Friends look up to child as a leader 108 (53.5) 147 (51.6) 1.1 (0.8, 1.6) 44 (57.9) 41 (32.5) 2.1 (1.4, 3.4) 
Other children hit, hurt /say nasty things to child 58 (28.7) 28 (9.8) 3.7 (2.2, 6.0) 30 (39.5) 28 (22.2) 2.5 (1.3, 4.8) 
Child does not feel included in lessons and activities 6 (3.0) 2 (0.7) 4.7 (2.7, 8.3) 3 (4.0) 3 (2.4) 0.6 (0.1, 3.0) 
Abbreviations HIV+ HIV-infected, HIV- HIV Uninfected, aOR odds ratio adjusted for age and sex. 
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Supplementary Table 5. School and Social Inclusion at School in Disabled Children With and Without HIV-infection  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic 
 
HIV+ 
with 
disability 
n=76 
n (%) 
 
HIV- 
with 
disability 
n=53 
n (%) 
 
aOR 
(95% CI) 
School inclusion as reported by children and their carers   
Currently enrolled in school 71 (93.4) 52 (98.1) 1.1 (0.3, 4.5) 
Enrolled in the same grade as peers 24 (31.6) 32 (57.1) 0.3 (0.1, 0.6) 
Ever repeated a year at school 32 (42.1) 12 (21.4) 3.3 (1.4, 8.0) 
Social inclusion as reported by children and their carers   
No help from teachers, if problem at school  2 (2.6) 1 (1.8) 0.1 (0.1, 8.1) 
No help from friends, if problem at school 11 (14.5) 1 (1.8) 0.5 (0.0, 0.9) 
Child has no friends to play with 2 (2.6) 0 (0.0) - 
Friends look up to child as a leader 26 (34.2) 27 (48.2) 0.5 (0.3, 1.1) 
Other children physically or verbally bully  30 (39.5) 3 (5.4) 11.3 (3.9, 39.8) 
Child excluded in lessons and activities 3 (4.0) 1 (1.8) 0.4 (0.0, 4.4) 
Abbreviations HIV+ HIV-infected, HIV- HIV Uninfected, aOR odds ratio adjusted for age and sex. 
 
